Biomarkers of brain injury after cardiac arrest; a statistical analysis plan from the TTM2 trial biobank investigators

[1]  K. Blennow,et al.  Serum markers of brain injury can predict good neurological outcome after out-of-hospital cardiac arrest , 2021, Intensive Care Medicine.

[2]  C. Callaway,et al.  Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest. , 2021, The New England journal of medicine.

[3]  J. Soar,et al.  European Resuscitation Council and European Society of Intensive Care Medicine Guidelines 2021: Post-resuscitation care. , 2021, Resuscitation.

[4]  T. Cronberg,et al.  Blood biomarkers of brain injury after cardiac arrest- a dynamic field. , 2020, Resuscitation.

[5]  J. Soar,et al.  Prediction of poor neurological outcome in comatose survivors of cardiac arrest: a systematic review , 2020, Intensive Care Medicine.

[6]  N. Lundbom,et al.  Neurofilament light as an outcome predictor after cardiac arrest: a post hoc analysis of the COMACARE trial , 2020, Intensive Care Medicine.

[7]  M. Wise,et al.  Serum GFAP and UCH-L1 for the prediction of neurological outcome in comatose cardiac arrest patients. , 2020, Resuscitation.

[8]  C. Callaway,et al.  Protocol for outcome reporting and follow-up in the Targeted Hypothermia versus Targeted Normothermia after Out-of-Hospital Cardiac Arrest trial (TTM2). , 2020, Resuscitation.

[9]  C. Callaway,et al.  Targeted hypothermia versus targeted Normothermia after out-of-hospital cardiac arrest (TTM2): A randomized clinical trial-Rationale and design. , 2019, American heart journal.

[10]  Philip S. Insel,et al.  Serum Neurofilament Light Chain for Prognosis of Outcome After Cardiac Arrest , 2019, JAMA neurology.

[11]  J. Ornato,et al.  Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study , 2018, The Lancet Neurology.

[12]  A. Šimundić,et al.  Internal quality assurance of HIL indices on Roche Cobas c702 , 2018, PloS one.

[13]  Philip S. Insel,et al.  Serum tau and neurological outcome in cardiac arrest , 2017, Annals of neurology.

[14]  L. Rasmussen,et al.  Return of spontaneous circulation and long‐term survival according to feedback provided by automated external defibrillators , 2017, Acta anaesthesiologica Scandinavica.

[15]  C. Ploner,et al.  Neuron-Specific Enolase Predicts Poor Outcome After Cardiac Arrest and Targeted Temperature Management: A Multicenter Study on 1,053 Patients , 2017, Critical care medicine.

[16]  M. Wise,et al.  Protein S100 as outcome predictor after out-of-hospital cardiac arrest and targeted temperature management at 33 °C and 36 °C , 2017, Critical Care.

[17]  R. Bellomo,et al.  Co-enrolment for the TAME and TTM-2 trials: the cerebral option. , 2017, Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine.

[18]  Johannes B Reitsma,et al.  STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration , 2016, BMJ Open.

[19]  M. Wise,et al.  Neuron-Speci fi c Enolase as a Predictor of Death or Poor Neurological Outcome After Out-of-Hospital Cardiac Arrest and Targeted Temperature Management at 33 C and 36 C , 2015 .

[20]  Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD) , 2015, Annals of Internal Medicine.

[21]  M. Wise,et al.  Targeted temperature management at 33°C versus 36°C after cardiac arrest. , 2013, The New England journal of medicine.

[22]  Bertil Romner,et al.  Scandinavian guidelines for initial management of minimal, mild and moderate head injuries in adults: an evidence and consensus-based update , 2013, BMC Medicine.

[23]  A. Agresti,et al.  Approximate is Better than “Exact” for Interval Estimation of Binomial Proportions , 1998 .